Exchange Surveillance
No active ASM or GSM measures on this stock.
Price band ± 20%
Price
Trading Data
range barsReturns
absolute and vs benchmark indexAbout the Company
Kovai Medical Center and Hospital Limited (KMCH) is an India-based company engaged in the running of hospitals. The Company is a 657-bed multi-disciplinary, super-specialty hospital located in Coimbatore, India. The hospital has more than 50 medical disciplines and is equipped with 20 operation theatres. Super specialty procedures, such as open heart surgeries, valve replacements, kidney transplants, hip and knee replacements, brain surgeries and spine surgeries are performed at the hospital. It also provides preventive health checkup programs, such as Premium Master Health Checkup with Cardiac CT Angio / Conventional Angio, Executive Master Health Checkup and KMCH Cancer Screening program. There are three satellite centers attached to KMCH, which are City Center (Ram Nagar), Erode Speciality Hospital (100 bed), and Erode Center (100 bed) with both in-patient and outpatient facilities.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- HQ
- Coimbatore, Tamil Nadu
- CEO & MD
- Nalla G Palaniswami
- Registrar
- GNSA Infotech (P) Ltd.
- Exchange
- NSE
- ISIN
- INE177F01017
Institutional Demand
passive ownership through ETFsContext
where this company sitsFrequently Asked
▶What is the share price of Kovai Medical Center & Hospital Ltd today?
Kovai Medical Center & Hospital Ltd (KOVAI) is trading at ₹5,973. The price shown is the latest available from the exchange feed and updates through the trading session.
▶What is KOVAI’s P/E ratio versus the sector?
KOVAI trades at a P/E of 26.8. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.
▶What is KOVAI’s dividend yield?
KOVAI has a dividend yield of 0.24%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.
▶What is KOVAI’s 52-week high and low?
KOVAI has traded between ₹2,576.65 and ₹6,444 over the past year. The Trading Data block shows where the current price sits inside that band.
▶What is the market capitalisation of Kovai Medical Center & Hospital Ltd?
Kovai Medical Center & Hospital Ltd has a market capitalisation of ₹6,883 crore.
▶What is KOVAI’s return on equity?
KOVAI reports a return on equity of 20.5%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Medical Care Facilities.
▶Who are KOVAI’s competitors?
The Peers block on this page lists other Medical Care Facilities companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.
▶What is KOVAI’s promoter holding?
Promoters hold 56.53% of KOVAI. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.
▶Which indices include KOVAI?
Index membership is listed in the Context block on this page, along with the weight KOVAI carries in each. That weight is what determines how much passive money tracks the stock.
▶Is Kovai Medical Center & Hospital Ltd a good buy?
We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from KOVAI’s own numbers. The judgement is yours.
KOVAI at a glance
Kovai Medical Center & Hospital Ltd operates in the Medical Care Facilities industry, part of the Healthcare sector. Kovai Medical Center & Hospital Ltd (KOVAI) last traded at ₹5,973, giving it a market capitalisation of ₹6,883 crore. The 52-week range is ₹2,576.65 to ₹6,444, and the price is 88% of the way up that range. It trades at a price-to-earnings ratio of 26.8. Promoters hold 56.53% of the company in the latest shareholding filing.
| Market cap | ₹6,883 crore |
|---|---|
| P/E | 26.8 |
| ROE | 20.5% |
| ROCE | 22.6% |